Scribd
Upload
112 views2 pages

BioSpectrum India: Oct 2017 Insights

BioSpectrum is India's first comprehensive biotech business monthly magazine launched in 2003. It provides coverage of life sciences sectors including biopharma, bioagriculture, and bioinformatics. It has emerged as a preferred platform for the Indian and Asian life sciences industry. The magazine is read by key policymakers, biotech professionals, and leaders in the pharmaceutical, clinical research, and biotech industries. The October 2017 issue discusses how India is bouncing back as a clinical research hub after facing setbacks in 2010 when drug approvals were delayed. Clinical trial approvals from the Drug Controller General of India have increased since 2016, and an online application system has improved the process. The growing clinical trial market and services in India are

Uploaded by

EricKankar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
112 views2 pages

BioSpectrum India: Oct 2017 Insights

BioSpectrum is India's first comprehensive biotech business monthly magazine launched in 2003. It provides coverage of life sciences sectors including biopharma, bioagriculture, and bioinformatics. It has emerged as a preferred platform for the Indian and Asian life sciences industry. The magazine is read by key policymakers, biotech professionals, and leaders in the pharmaceutical, clinical research, and biotech industries. The October 2017 issue discusses how India is bouncing back as a clinical research hub after facing setbacks in 2010 when drug approvals were delayed. Clinical trial approvals from the Drug Controller General of India have increased since 2016, and an online application system has improved the process. The growing clinical trial market and services in India are

Uploaded by

EricKankar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

To ,

Prof. M S Swaminathan
Founder MSSRF
M S Swaminathan Research Foundation
3rd Cross Street, Institutional Area, Taramani
Chennai 600 113, India

Subject : BioSpectrum Journal Vol.15 Issue 10 October 2017

Respected Sir ,

The BioSpectrum India edition was launched in March 2003 and is India's first
comprehensive biotech business monthly magazine. It provides comprehensive coverage
of the exciting happenings in life sciences, which include BioPharma, BioAgriculture,
BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the
emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has
emerged as the most preferred platform to engage the life sciences industry in India and
Asia Pacific. It is also widely accepted by research and academia community. Top key
policy makers in the Central and state government use the magazine as a platform to
reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy
makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are
from among the key Policy Makers, Key Executives and the Influencer's in
Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research,
Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants,
Fund Managers etc

BioSpectrum October 2017 Issue


India to Bounce Back As clinical Research Hub
India was considered as an all time favoured destination for clinical trials . Most of the
outsourced studies are phase III studies where India has a diverse pool of patients. After
2010 there was major setback in the CRO industry in India . Drug controller General of
India (DGCI) approvals were delayed and multinational sponsors stepped back
outsourcing studies to India . But Slowly post 2016 DGCI has been generous enough in
proving approvals and online application system has brought a lot of difference . Indian
Clinical Trial market & clinical trial services is expected to grow significantly along with
trends.

Warm Regards,

Ravindra Boratkar
Managing Editor & Publisher
BioSpectrum India |BioSpectrum Asia |NuFFooDS Spectrum
MM ACTIV SCI-TECH COMMUNICATIONS PVT LTD
[Link]
To ,

Prof. M S Swaminathan
Founder MSSRF
M S Swaminathan Research Foundation
3rd Cross Street, Institutional Area, Taramani
Chennai 600 113, India
Tel: +91 (44) 22541229, +91 (44) 22541698

You might also like